Denmark confirmed its first case of the more transmissible mpox clade Ib variant on April 14, 2026, marking a shift from the milder strain seen in the 2022 outbreak. The infected person returned from abroad with mild symptoms after sexual contact, and authorities found no close contacts in Denmark. Health officials say the overall risk remains low, but the arrival of this variant raises questions about whether Denmark’s vaccination efforts for high-risk groups go far enough.
I’ve watched Denmark handle infectious disease surveillance for years now, and the system works. When Statens Serum Institut announced the clade Ib case two weeks ago, the response was textbook: trace contacts, test, assess risk, inform the public without panic. No close contacts were identified. The person had mild symptoms. Life went on.
But this isn’t the same mpox that circulated here in 2022. That outbreak, driven by clade IIb, gave Denmark 192 cases in its first year and then largely faded. By 2025, only 18 cases were reported. As of April 14, Denmark had logged 224 clade IIb cases total since the start of the global outbreak. The new clade Ib variant, first detected in Central Africa in 2023, shows higher transmissibility and potentially greater severity, though data on non-African cases remains limited.
A Different Strain, A Different Risk Profile
The distinction between clades matters. Clade Ib has enabled sustained person-to-person transmission in Europe and the Americas since October 2025, particularly among networks of gay, bisexual, and other men who have sex with men. The UK has confirmed 45 clade Ib cases as of March 31, 2026, mostly in England, and raised its importation risk assessment to high. Across Europe, 8,481 mpox cases have been confirmed in 40 countries as of late January 2025, according to available data.
Globally, the numbers tell a story of two overlapping epidemics. From January 2022 through March 31, 2026, the WHO recorded 181,164 confirmed cases and 492 deaths across 144 member states. In 2025 alone, 53,562 cases and 219 deaths were reported. By February 28, 2026, another 2,794 cases had been logged. The clade Ib variant now dominates new outbreaks outside Africa.
Denmark’s preparation hinges on diagnostics, surveillance, and vaccination. Since mid-2022, the country has vaccinated 6,111 high-risk individuals with the Imvanex pox vaccine. That’s a solid effort for a small population, but it’s not universal coverage even within the most vulnerable groups. A Danish cohort study of 727 men who have sex with men found 13 infections, or 1.8 percent, with a rate of 35.8 per 1,000 person-years. Those with prior sexually transmitted disease history faced seven times the risk after adjustment.
Vaccines Work, But Uptake Isn’t Complete
I’ve seen vaccine willingness run high among Copenhagen’s MSM community, yet uptake remains incomplete despite the availability of health services that are typically accessible to residents. Reinfections have been documented, raising concerns about immunity duration and the need for possible boosters. The Danish Health Authority, as reported by TV2, has said the clade Ib case does not change the current risk assessment and that overall infection risk in Denmark remains low.
That reassurance is grounded in reality, but it also reflects a calculus that weighs population-level risk over individual vulnerability. For expats living here, especially those in higher-risk networks, understanding Danish healthcare access and vaccination eligibility is critical. The system is good at surveillance and contact tracing, but proactive vaccination outreach could be stronger.
California health officials urged high-risk San Francisco residents to get vaccinated after detecting a clade Ib-like case in mid-April 2026, calling it a potentially more severe strain. The US has ordered $63 million worth of Jynneos vaccine, enough for one million doses, for delivery by 2026. Canada reported 296 mpox cases in 2025. The global picture shows clade Ib spreading through networks that cross borders easily, especially in cities with active international travel and nightlife scenes. Copenhagen fits that profile.
What This Means for Expats and High-Risk Groups
Denmark is well prepared to identify infected individuals, according to SSI, and the infrastructure is solid. But preparation and prevention are different things. The 2022 outbreak peaked early here and subsided, partly due to behavior change within affected communities and partly due to luck. Clade Ib’s higher transmissibility means that same luck may not hold.
For expats navigating Denmark’s health system, the lesson is straightforward: if you’re in a high-risk group, get vaccinated. Imvanex has been available since 2022, and while it targets clade IIb, it offers cross-protection against clade Ib. The European Centre for Disease Prevention and Control notes low secondary spread at mass gatherings, with one to six cases per event, but the risk isn’t zero. Denmark’s first clade Ib case was travel-related and sexually transmitted, a pattern seen across Europe.
The Danish approach favors targeted vaccination over blanket mandates, and that makes sense given the epidemiology. But targeted only works if the targets are reached. Vaccine hesitancy isn’t the issue here; access and awareness are. Some expats may not know they’re eligible, or may struggle with language barriers when booking appointments. Others may simply assume the risk has passed because case numbers dropped after 2022.
SSI’s surveillance caught this case quickly, and no domestic transmission has been detected. That’s good. But as clade Ib circulates more widely in Europe, the odds of additional importations rise. Denmark’s low overall risk assessment holds for now, but the margin is narrower than it was two years ago. For those of us who’ve made Denmark home, staying informed and vaccinated isn’t alarmist. It’s just sensible policy applied at the individual level, especially in light of health initiatives targeting vulnerable populations.
Sources and References
The Danish Dream: Danish Healthcare Explained for Tourists & Expats
The Danish Dream: Health Insurance in Denmark
The Danish Dream: Denmark’s Youth Nicotine Challenge: Health Initiatives Emerge
TV2: Særligt én gruppe skal være opmærksom på mpox
